IPS-Integrated Project Services, LLC / WuXi BiologicsWuXi Biologics has agreed to sell its Dundalk vaccine manufacturing facility to Merck, a move that will enhance asset efficiencies and allow the company to focus on CDMO services at its other global sites.
Tag Archive for: Oral Macrocycle Drugs
Orbis MedicinesOrbis Medicines secures €90m in Series A funding to accelerate the development of oral macrocycle drugs, leveraging automated chemistry and machine learning.